Hallie Kuhn, Ph.D. is Vice President, Science & Technology, at Alexandria Real Estate Equities, Inc. and its corporate venture arm, Alexandria Venture Investments. In her role, Dr. Kuhn oversees strategic venture investments across Southern California, with a portfolio of over 25 life science investments. She also works closely with Alexandria’s real estate development team to support business development and tenant underwriting in San Diego and Greater LA.
Formerly, Dr. Kuhn was a Principal at LS Polaris Innovation Fund, a Boston-based VC-fund specializing in early-stage life science investments. She concurrently served as Chief of Staff for Polaris Partner, Amy Schulman, where she oversaw business development and operations for Polaris Portfolio companies, including Olivo Laboratories (acquired by Shiseido) and Lyndra Therapeutics. Prior to Polaris, she was a Senior Consultant at Clearview Healthcare Partners, supporting biopharma companies on strategic projects spanning the full cycle of drug development and commercialization. Dr. Kuhn holds a Ph.D. in Systems Biology from Harvard University and was a Churchill Scholar at Cambridge University. She is a recipient of a National Science Foundation Graduate Fellowship, National Defense Science and Engineering Fellowship and Harvard Ashford Fellowship. She holds a B.S. from Harvey Mudd College.